In the pharmaceutical industry, this Triple Combination is the “Gold Standard” for treating the Common Cold and Flu. As a pharmacist and manufacturer, I view this formulation as a “Synergistic Multi-Symptom Relief” kit. Each component is technically selected to address a specific physiological response to viral upper respiratory tract infections.
At your WHO-GMP facility in Mumbai, this combination is likely one of your high-volume SKUs for “Cold & Flu” syrups or tablets, especially for international B2B tenders where comprehensive symptom management in a single dose is preferred.
Therapeutic Profile: Multi-Symptom Target
This formulation is designed to provide relief across three distinct pathways:
| Component | Class | Primary Function |
| Paracetamol (500 mg) | Analgesic/Antipyretic | Reduces fever and treats body aches/headaches. |
| Phenylephrine HCl (5 mg/10 mg) | Nasal Decongestant | Shrinks swollen nasal membranes to open the airway. |
| Chlorpheniramine Maleate (2 mg) | Antihistamine | Stops sneezing, runny nose, and watery eyes. |
Mechanism: The Triple-Action Defense
This combination works by simultaneously addressing the central nervous system, the vascular system, and the immune response:
Analgesic Action (Paracetamol): It inhibits prostaglandin synthesis in the brain to reset the body’s “thermostat” (fever) and raise the pain threshold.
Decongestant Action (Phenylephrine):
It acts as a selective $\alpha_1$-adrenergic receptor agonist. It constricts the dilated blood vessels in the nasal passages, which reduces swelling and mucus “leakage.”
Antihistamine Action (Chlorpheniramine):
It is a first-generation H1-receptor antagonist. It blocks the binding of **Histamine** to its receptors, which shuts down the inflammatory "allergic" response (sneezing and itching). It also has an anticholinergic effect that helps "dry up" a runny nose.
The Pharmacist’s “Technical Warning”
-
The “Drowsiness” Factor: As a pharmacist, I must emphasize that Chlorpheniramine (2 mg) is a first-generation antihistamine that crosses the blood-brain barrier. It causes significant sedation. Patients should not drive or operate machinery.
-
Hypertension Alert: Phenylephrine is a vasoconstrictor. It can raise blood pressure and should be used with extreme caution in patients with hypertension, hyperthyroidism, or cardiovascular disease.
-
The “Liver Ceiling”: Because it contains 500 mg of Paracetamol, warn patients not to take other paracetamol-containing products to avoid exceeding the 4g/day limit.
-
Glaucoma/Prostate Risk: Due to the anticholinergic effects of the antihistamine, this drug can worsen symptoms of narrow-angle glaucoma or enlarged prostate (urinary retention).
The Manufacturer’s Perspective: Technical & Export
From a production and B2B standpoint at your facility in Mumbai:
-
The “Comprehensive SKU” USP: On your digital marketplace, highlight this as a “Complete Cold Management” product. For B2B buyers in Africa and Southeast Asia, a single tablet that replaces three separate medicines is a powerful cost-saving and compliance-boosting argument.
-
Stability for Export: This combination is stable but light-sensitive. Utilizing Alu-Alu or Opaque PVC/PVDC blister packaging is the industry standard for ensuring a 36-month shelf life in Zone IVb tropical regions.
-
Dossier Support: We provide full WHO-standard CTD/eCTD Dossiers for this FDC (Fixed-Dose Combination) to support your firm’s registration in international tenders for “Essential Respiratory Medicines.”